Successful Rescue and Transition of a Phase I Oncology Study for a US Biotech Company

Overview A US biotech company's Phase I oncology study had stalled under the management of…

Article Date
January 29, 2026

This article is featured on another website.

Go to article

Related posts

Browse all articles
January 26, 2026

Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier

January 26, 2026

Interview: Biosimilars, a market reaching an inflection point — a conversation with Frederic Bouvier

January 15, 2026

Q&A with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics

January 15, 2026

Q&A with Sean A. MacDonald, Chief Executive Officer at Kainova Therapeutics